<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sladojevic N</submitter><funding>National Institute for General Medical Science</funding><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>57-70</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4273560</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67</volume><pubmed_abstract>Proinflammatory mediators trigger intensive postischemic inflammatory remodeling of the blood-brain barrier (BBB) including extensive brain endothelial cell surface and junctional complex changes. Junctional adhesion molecule-A (JAM-A) is a component of the brain endothelial junctional complex with dual roles: paracellular route occlusion and regulating leukocyte docking and migration. The current study examined the contribution of JAM-A to the regulation of leukocyte (neutrophils and monocytes/macrophages) infiltration and the postischemic inflammatory response in brain ischemia/reperfusion (I/R injury). Brain I/R injury was induced by transient middle cerebral artery occlusion (MCAO) for 30min in mice followed by reperfusion for 0-5days, during which time JAM-A antagonist peptide (JAM-Ap</pubmed_abstract><journal>Neurobiology of disease</journal><pubmed_title>Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury.</pubmed_title><pmcid>PMC4273560</pmcid><funding_grant_id>T32 HL007517</funding_grant_id><funding_grant_id>R01 NS062853</funding_grant_id><funding_grant_id>NS034709</funding_grant_id><funding_grant_id>R01 GM029507</funding_grant_id><funding_grant_id>R01 NS034709</funding_grant_id><funding_grant_id>GM29507</funding_grant_id><funding_grant_id>NS062853</funding_grant_id><funding_grant_id>R37 GM029507</funding_grant_id><funding_grant_id>GM61656</funding_grant_id><funding_grant_id>R56 NS062853</funding_grant_id><funding_grant_id>R01 GM061656</funding_grant_id><pubmed_authors>Keep RF</pubmed_authors><pubmed_authors>Sladojevic N</pubmed_authors><pubmed_authors>Sarma JV</pubmed_authors><pubmed_authors>Stamatovic SM</pubmed_authors><pubmed_authors>Grailer JJ</pubmed_authors><pubmed_authors>Ward PA</pubmed_authors><pubmed_authors>Andjelkovic AV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury.</name><description>Proinflammatory mediators trigger intensive postischemic inflammatory remodeling of the blood-brain barrier (BBB) including extensive brain endothelial cell surface and junctional complex changes. Junctional adhesion molecule-A (JAM-A) is a component of the brain endothelial junctional complex with dual roles: paracellular route occlusion and regulating leukocyte docking and migration. The current study examined the contribution of JAM-A to the regulation of leukocyte (neutrophils and monocytes/macrophages) infiltration and the postischemic inflammatory response in brain ischemia/reperfusion (I/R injury). Brain I/R injury was induced by transient middle cerebral artery occlusion (MCAO) for 30min in mice followed by reperfusion for 0-5days, during which time JAM-A antagonist peptide (JAM-Ap</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Jul</publication><modification>2025-04-19T14:41:22.84Z</modification><creation>2019-03-27T01:42:12Z</creation></dates><accession>S-EPMC4273560</accession><cross_references><pubmed>24657919</pubmed><doi>10.1016/j.nbd.2014.03.010</doi></cross_references></HashMap>